Total Payments
$230,421
2023 Payments
$20,637
Companies
37
Transactions
1,194
Medicare Patients
1,173
Medicare Billing
$208,927
Payment Breakdown by Category
Other$177,605 (77.1%)
Travel$33,057 (14.3%)
Food & Beverage$19,255 (8.4%)
Education$353.44 (0.2%)
Gifts$151.14 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $174,605 | 95 | 75.8% |
| Travel and Lodging | $33,057 | 66 | 14.3% |
| Food and Beverage | $19,255 | 1,009 | 8.4% |
| Honoraria | $3,000 | 2 | 1.3% |
| Education | $353.44 | 10 | 0.2% |
| Gift | $151.14 | 12 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $98,993 | 133 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $39,016 | 115 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $29,940 | 122 | $0 (2021) |
| Allergan, Inc. | $26,739 | 169 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $20,320 | 37 | $0 (2021) |
| Validus Pharmaceuticals LLC | $3,552 | 44 | $0 (2020) |
| Takeda Pharmaceuticals America, Inc. | $1,338 | 3 | $0 (2017) |
| ITI, Inc. | $1,245 | 31 | $0 (2021) |
| Lundbeck LLC | $1,142 | 73 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $736.22 | 38 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $20,637 | 21 | AbbVie Inc. ($20,449) |
| 2022 | $63,613 | 49 | ABBVIE INC. ($63,568) |
| 2021 | $16,661 | 145 | AbbVie Inc. ($14,975) |
| 2020 | $14,481 | 198 | Allergan, Inc. ($10,175) |
| 2019 | $31,798 | 247 | Avanir Pharmaceuticals, Inc. ($10,726) |
| 2018 | $42,146 | 234 | Avanir Pharmaceuticals, Inc. ($13,380) |
| 2017 | $41,086 | 300 | Avanir Pharmaceuticals, Inc. ($14,853) |
All Payment Transactions
1,194 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/29/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: Neuropsychiatry | ||||||
| 09/28/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $57.50 | General |
| Category: Neuropsychiatry | ||||||
| 04/06/2023 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2023 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2023 | AbbVie Inc. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $964.25 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $997.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $1,313.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2023 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $631.62 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $619.41 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $211.64 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $47.21 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $45.70 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $111.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $1,811.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $110.24 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 531 | 1,606 | $229,126 | $106,353 |
| 2020 | 5 | 642 | 1,957 | $265,761 | $102,575 |
Total Patients
1,173
Total Services
3,563
Medicare Billing
$208,927
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 362 | 1,333 | $173,290 | $80,029 | 46.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 115 | 116 | $32,016 | $14,205 | 44.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 86 | $15,910 | $8,753 | 55.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 32 | $3,840 | $1,811 | 47.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 19 | $3,230 | $1,450 | 44.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 20 | $840.00 | $105.50 | 12.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 424 | 1,602 | $206,050 | $77,880 | 37.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 163 | 163 | $43,829 | $18,316 | 41.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 22 | 43 | $7,310 | $3,417 | 46.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 30 | $3,600 | $1,734 | 48.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 18 | 119 | $4,972 | $1,227 | 24.7% |
About Dr. Antonio Cusi, M.D
Dr. Antonio Cusi, M.D is a Psychiatry healthcare provider based in Jacksonville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487643151.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Antonio Cusi, M.D has received a total of $230,421 in payments from pharmaceutical and medical device companies, with $20,637 received in 2023. These payments were reported across 1,194 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($174,605).
As a Medicare-enrolled provider, Cusi has provided services to 1,173 Medicare beneficiaries, totaling 3,563 services with total Medicare billing of $208,927. Data is available for 2 years (2020–2021), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Jacksonville, NC
- Active Since 10/17/2005
- Last Updated 04/25/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1487643151
Products in Payments
- VRAYLAR (Drug) $125,391
- NUEDEXTA (Drug) $38,932
- REXULTI (Drug) $29,675
- Trintellix (Drug) $21,133
- Equetro (Drug) $3,552
- CAPLYTA (Drug) $1,245
- ABILIFY MAINTENA (Drug) $1,042
- INGREZZA (Drug) $656.20
- TRINTELLIX (Drug) $596.15
- VYVANSE (Drug) $568.23
- Fanapt (Drug) $475.80
- INVEGA SUSTENNA (Drug) $461.58
- AUSTEDO (Drug) $456.07
- Adzenys XR-ODT (Drug) $366.74
- Dayvigo (Drug) $357.56
- ARISTADA (Drug) $321.60
- Aristada 441 mg (Drug) $320.71
- Neupro (Drug) $304.64
- BELSOMRA (Drug) $296.81
- BRINTELLIX (Drug) $291.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Jacksonville
Mr. Amit Vijapura, Md, MD
Psychiatry — Payments: $604,540
Psychiatry $604,540
John Joyce, M. D, M. D
Psychiatry — Payments: $220,986
Psychiatry $220,986
Dr. Sagar Vijapura, M.d, M.D
Psychiatry — Payments: $94,231
Psychiatry $94,231
Dr. Hiten Kisnad, M.d, M.D
Psychiatry — Payments: $89,894
Psychiatry $89,894
Dr. Alina Galliano-Pardo, M.d, M.D
Psychiatry — Payments: $25,867
Psychiatry $25,867
Ajay Veeragandham, Md, MD
Psychiatry — Payments: $21,559
Psychiatry $21,559